Tag Archives: ASHG2009

The Economist Mangles Disease Genetics

The Economist has a rather distressingly bad article by the evolutionary psychologist Geoffrey Miller, about the supposed general failure in human disease genetics over the last 5 years. The thesis is that Genomes Wide Association Studies (GWAS) for common diseases have been a failure that geneticists are trying to keep hidden, and that the new techniques required to solve the problem of disease genetics will raise ‘politically awkward and morally perplexing facts’ about the different traits and evolutionary histories of races. The former claim is pretty much the same as Steve Jones Telegraph article earlier this year, and is just as specious. I will look at both claims separately.

A quick point of terminology: Miller uses ‘GWAS’ to refer to studies that look for disease association in common variants using a genotyping chip, and acts as if sequencing studies are not, in fact, GWAS. In fact, a sequencing association study is just another type of GWAS, just looking at a larger set of variants.
Continue reading

ASHG: Quantifying Relatedness and Active Subjects in Genome Research

Well, the American Society of Human Genetics Annual Meeting is coming to a close for another year. My talk is done and dusted, so I no longer have to lie awake at night worrying that I will forget everything other then the words to “Stand By Your Man” when confronted by the crowd. My white suit is now more of an off-white suit, with regions of very-off-white and pretty-much-entirely-out-of-sight-of-white. I’m looking forward to getting back home to catch up on my sleep.

For the last time, I’m going to give a little summary of talks today that I thought were interesting, or gave some indication of where genetics may be heading in the future. I will write up some more general thoughts about the meeting in the next few days, as soon as the traveling is out of the way and my mind has recharged.

If you would like some second opinions on the conference, GenomeWeb has a number of articles, including a couple of short summaries, as well as a nice mid-length article about the 1000 Genomes session; there are also a number of articles over at In The Field, the Nature network conference blog.
Continue reading

ASHG: Finding Mendelian Mutations and Inclusive Population Genetics

Third day down, one to go. I am starting to suffer from conference fatigue somewhat. I’m not going to any other talks this evening, so I am going to try and get some relaxation time in from this point on. But first; the summary of Day 3.

Today I saw a lot of talks over three sessions, and many of them were very interesting. However, I won’t talk about everything, or even my favourite talks. I’ll go for the talks that seem to tie together into nice stories about a few directions genetics seems to be heading in.
Continue reading

ASHG: Statistical Genomics and Beyond GWAS in Complex Disease

The second day of the American Society of Human Genetics Annual Meeting is drawing to a close; here’s a lowdown of what talks I’ve enjoyed today.

Remember, follow @lukejostins on Twitter if you want more up-to-the-minute details on the ASHG talks.
Continue reading

ASHG: Chatting with the Sequencing People

While I am here, I though I’d take the chance to chat to the people at the booths for the three major Second Gen sequencing platforms (Illumina, SOLiD and 454). It was surprisingly fun, the guys I talked to all seemed enthusiastic, and it was nice to find out where the scientists in the companies think the technology is going.

In the interests of openness: the 454 booth gave me a cool T-shirt and poster, so this may well have biased my opinion of them
Continue reading

ASHG: Rare Variants, and the 1000 Genomes Project

Hello all (it is taking every bone in my body not to say ‘Aloha’ here).

So, today was the first real day of the ASHG Annual Meeting; after accidentally falling asleep for basically all of yesterday, it was good to finally see some familiar faces and dig my teeth into some real science.

I’m going to write a little about the first couple of sessions I’ve seen, and say what sort of themes are being shouted loud enough to get into my jetlagged mind. I have also been tweeting the conference at quite a high frequency (about 30 tweets so far), and in more detail than I have given here; follow me on @lukejostins if you are interested. To see all the ASHG twittering, check out #ASHG2009.

The blogs posts over the next few days will be aimed mostly at those who are, at least vaguely, In The Know about genomics. However, if there are people who would like a less jargonistic lowdown of the conference, please leave a comment and I’ll see what I can do.
Continue reading